OPC-34712

· Otsuka Pharmaceutical Development & Commercialization, Inc.

Drug timelines are a Plus or Pro feature.

16 regulatory and trial events tracked for OPC-34712, covering 2010-05-07 to 2023-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder [Phase 2]

See pricing